Mar11

Reality-based research – do you know what it is really all about?

I Word Cloudam often asked to explain to both agency colleagues and clients what the Behavioral Insights team does, and how it differs from other kinds of research.

Here is what I tell them…

Years ago, one strategically minded agency leader thought that he could do a much better job helping his pharmaceutical marketing and advertising clients if he knew what was really said when physicians and patients got together for their visits. He was right. Years later, we have recorded over 4,000 office visits and 8,000 corresponding post-visit interviews with healthcare professionals in over 20 therapeutic categories, along with their patients and often their loved ones—creating a whole lot of words and actions to analyze. Now we have a much better understanding of physician and patient dialogue and behavior—and a lot of insight into what goes on during real-world interactions in healthcare.

Over time we have broadened our offerings, but overall, we conduct primary research in real-world settings that focuses on healthcare dialogue and behavior. We do this by accessing techniques such as ethnography to observe our targets in physicians’ offices, their homes and work places, and while on the go. We analyze the data with sociolinguistic techniques. By monitoring social media, we can even take a look at what they write about online in open forums, and analyze their dialogue. We know that when a person feels less inhibited by the constraints they often experience when talking with healthcare professionals in person, they are able to ask questions and raise topics they normally shy away from.

From years of studying human behavior, we also know that what people say they do and what they actually do are not always aligned. We have heard it all, from asthma patients saying their daily lives are not impacted yet they gave away their beloved pet and ripped out their carpets, to spinal cord injury patients saying they accept their condition, but refusing to put a ramp in front of their home. We look to get under the surface and understand what is really happening, where there are gaps in communication, and what the intended and unintended consequences of these interactions are.Dialogue

We don’t stop there. Does the term computational linguistics sound intriguing to you? If so, you’re not alone. We can take a look at millions of words by using industry publications and see what words are most often used together and the frequency of words used to help your clients describe and own the scientific and clinical story.

Knowing so many of my colleagues are curious by nature, I am guessing you really want to know what we learned from our many years of doing this research! Well, you don’t have to wait much longer because we have a white paper, Top 7 Insights from Years of Observing Real-world Healthcare Communication, coming out shortly from our very own sociolinguist, Katy Hewett!

Of course, you can also just ask us! In fact, if you work directly with clients, make sure to talk to us about how we can share these exciting and unique offerings with them, and discuss what benefits these different offerings have for your brand.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, behavior change, Brand Awareness, Clients, Creativity, Design, Great Ideas, Health & Wellness, Healthcare Communications, Innovate, Patient Communications, Patient Recruitment, Social Media, Strategy | Comments closed
Jan25

Top Picks From CES 2016

Author Pic CES

Ogilvy CommonHealth’s Ashley Evens (left) and Nelson Figueiredo (right)

Ogilvy CommonHealth’s Ashley Evens, senior engagement strategist and Nelson Figueiredo, VP, director of technology, applied their experience as a healthcare communicators to identify the most impactful technologies from their year’s CES.

Each year, technologists, strategists, start-ups, major manufacturers, and consumers gravitate to Las Vegas for CES. This is becoming the premier event to showcase new consumer electronics, technology, and products. With the growth of healthcare as a key technology topic, CES is also an important venue for healthcare brands and influencers.

Ogilvy CommonHealth’s Ashley Evens and Nelson Figueiredo spent several days on the floor at CES and have curated the following list of products and technologies to watch:

CaptureProof: like HIPAA-secure Snapchat…only better

CaptureProof is a new HIPAA-secure platform for sharing media and data between patients and providers. CaptureProof allows doctors to monitor patient progress and symptoms, triage via media, consult colleagues, and link to wearable devices and EHRs.

It’s recently been used in pilots for remote physical therapy (reducing in-person appointments by 75% and resulting in an overall cost savings of $7,500 per patient) and its diagnostic capabilities are currently being studied by the Epilepsy Monitoring Unit at MAYO Neurology.

Currently an invite is necessary to set up an account. However, we’re in discussion about the various ways brands and agencies can utilize the platform and looking forward to developing partnership opportunities with them.

CaptureProof

Holograms still have show-stopping power

With the exception of Shaq walking the showroom floor, preordering robots, when it comes to show-stopping power, hologram technology still reigns supreme.

The Kin-mo booth caused the steadiest stream of pandemonium and buzz at the event, literally, stopping hordes of people in their tracks and compelling them to ask questions and snap pictures and video.

Here at Ogilvy CommonHealth we’re exploring the practical application of Holograms in medical education and are working on making the technology less cost-prohibitive for use in the field.

Holograms from CES2016

Meet flic, the wireless smart button that could revolutionize the way patients communicate with providers

Flic is a small wireless button that you can stick anywhere. It can be programmed to send data and commands to apps on Android or iOS devices.

Swedish developers, Shortcut Labs, designed flic with simplicity, accessibility and safety in mind. It’s currently being used to streamline everyday tasks like controlling your connected home, selecting entertainment and ordering food and taxis.

But the ease of use makes it an intriguing solution for things like symptom reporting and tracking between patient and provider, treatment adherence, atmospheric or environmental controls, and accessibility for patients with limited mobility.

VR was king at CES and controller tech is on the rise

This year the Virtual Reality headset manufacturers exhibiting at CES were too numerous to count and VR environments demoing experiences in space, tech, automotive, entertainment, health and fitness were among the most engaging booth draws on the showroom floor.

While everyone seems to agree that VR is going to revolutionize medical education, it’s recent advances in VR controllers and the impact that they might have on rehabilitation and treatment methods that we found most inspiring at CES this year.

Two groups in particular, 3DRudder and Rink, are leading innovation in foot and hand controls, respectively, and are excited to explore applications for their devices in the healthcare space. Each offer the opportunity to gamify the treatment process in new and exciting ways and extend mobility exercises into the VR realm.

RINK

Sensum, the marketing industry’s new emotions experts

Turning emotions into data, measuring advertising’s effect on the subconscious, tracking the cognitive unconscious, things that used to be qualitative can now be quantitative thanks to Belfast-based Sensum.

They’re already working with some of the biggest media companies and agencies in the world to measure the effectiveness of messages, customer engagement, and usability.

Whether it’s a live event, or a product that needs to be tested for implicit response, new packaging, or a video message, Sensum has the platform and technology you need to capture the real-time emotional response from your audience.

They’re also the creators of the EmoCam.

CES is proving to be a venue for innovators and entrepreneurs to showcase their solutions for healthcare. As the empowered patient and modern physician begin to leverage new technology for better outcomes, there is an increasingly more important role for connected medicine, wearables, and mobile technology to help us live healthier lives.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, Augmented Reality, behavior change, Brand Awareness, Branding, Consumer Electronics Show, Creativity, Culture, Design, Digital, Global Marketing, Great Ideas, Healthcare Communications, Patient Communications, Technology, Wearable Health Technology | Comments closed
Nov4

I’m excited about the new Facebook Search!

Facebook Search

The new Facebook Search feature is a pretty robust tool that we should be excited about as both marketers and users. Here are a few thoughts, as well as a few predictions around where Facebook might be going with this.

As a regular Facebook user, I was really impressed by the amount of content I was served up when I did a simple search for “cough.” The results were divided into three buckets: Pages, Friends and Groups, and Public Posts – and the keyword was highlighted in each of the posts. There is also a sub-navigation that lets users filter results by Top, Latest, Photos, Videos, Places, and even Apps and Events. Having immediate access to relevant posts that were outside my network was really refreshing, and it was cool to see who was talking about coughs within my network specifically. It will be interesting to see how the results will update during a political event or a big game. In many ways, it reminds me of the way current events can be followed on Twitter.

For users who have privacy concerns, this new feature should raise red flags. Facebook provides users with privacy settings in the actual post window that allow them to choose who can view their post. Those rules will continue to hold true within the search results. If your post is only visible to your friends, then it would only appear in the search results of users in your immediate network. If it is a public post, it will be visible outside of your network. The same applies to comments on posts, as well.

As marketers, we should be excited about the role that brands can play within this new space. Since this is new to all of us, we don’t yet understand the rhyme or reason behind the order of the posts that are displayed when a user searches. That being said, this is a great opportunity for brands to ensure their social engagement strategy is buttoned up. Brands need to be ultra-focused on creating relevant content on their feeds that is keyword-rich, and that includes image and video descriptions.

It will be a matter of time before we are able to advertise in this space. Like Google, media buys will likely dictate your brand’s rank within the search results in the Pages section, with native advertising appearing throughout the Public Posts. When we factor in the Buy Products feature, it’s easy to see how Facebook can begin to position itself as a direct competitor to Google and Amazon, although I think that’s still some ways away.

Visit http://search.fb.com/ to hear all about it from the proverbial horse’s mouth.

This article was originally posted on Ivan Ruiz Graphic & Web Design.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, Analytics, Branding, Content Strategy, Creativity, Data, Design, Digital, Digital Advertising, Health & Wellness, Healthcare Communications, Media, Media Placement, Social Media, Strategy, Technology | Comments closed
Oct20

Do we need a healthcare awards show?

Health_AwardsWith all but one or two award shows done and dusted for the year, I can honestly say that I have been delighted to see the standard of creativity in healthcare grow from strength to strength. It’s been inspiring, but at the same time it’s been frustrating.

Recently I judged at one of the major healthcare award shows along with some of the industry’s best—people I respect deeply.

We had some interesting conversations around a few of the entries. The main discussion point being, is this really health?

Saving dogs, a hashtag for mums about how amazing their child is, helping hungry people or recruiting medical staff for the armed forces—for me seems broader than health or not even health at all.

We did discuss the fact that it lifted the game in terms of thinking and execution, but it was acting as a guide stick of where we need to be rather than being a true health entry.

But do these types of entries make the interactive visual aid that has been under the red pen of medical advisors feel boring? Does it make the print ad idea that has made it through the treacherous journey of a pharmaceutical marketing department and research group feel flat? Does it make the medical education program that the regulatory body has scrutinised to the inch of its life look dull?
The answer is yes.

There is no place for pharmaceutical work in a current healthcare awards show. If it isn’t bringing you on the brink of tears or changing the world as we know it, it won’t get a real look in. It will be blindsided.

So should we have a healthcare awards show? Why not simply have a health category in the mainstream shows?

Think we know the answer to that one.

The bigger question is (and part of the reason why award shows were there in the first place), how are we going to lift pharmaceutical communications to a better standard? How are we going to inspire true healthcare agencies that live and breathe health every day?

I believe they deserve to be judged in a very different way.
The idea and great execution, without a doubt should be there. But pharmaceutical communications goes deeper than that. It’s the strategy that creatively and intelligently weaves its way through the minefield of regulations and treatment indications. The medical writing that’s taken highly scientific information and made it code-compliant yet highly persuasive to a cynical physician.

So with all this in mind, I believe we do need an awards show for healthcare, but it has to be very different from the shows we currently have. They are mostly celebrating work that’s for the good of man (or animal) kind and I believe you could tack anything to that and call it health.

Pharma is a weird and wonderful world and a very specialised one, so when it comes to judging creativity, should it not be seen through a slightly different lens?

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, agency life, awards, behavior change, Branding, Clients, Creativity, Culture, Design, Great Ideas, Health & Wellness, Healthcare Communications, Innovate, Marketing, Media, Medical Education, Medicine, Pharmaceutical, Strategy | Comments closed
Oct5

At the crossroads of health, wellness, technology, and marketing

2015 Marketing Summit Template_BLOGIt was a privilege to attend the 2015 Marketing Summit hosted by Ogilvy CommonHealth and eConsultancy. As the producer at the event, I was able to spend some time with each of the presenters. I was also able to hit the 10,000-step mark on my Fitbit by 3 pm—I’ll circle back to wearables later. I was most impressed by the diversity of speakers who are playing at the crossroads of health, wellness, technology, and marketing. The people I met and the messages I heard made me extremely excited on two different fronts: as a human being, and as a marketer.

As a human being, I was excited about the ideas surrounding personalized health that we heard throughout the day—especially since I moonlight as a fitness instructor.

Among them was Jeff Arnold from Sharecare, who is empowering consumers to take charge of their health by delivering personalized resources and expert advice through their online health profiles. Melissa Bojorquez of Physicians Interactive talked to us about technology’s unique power to help people connect with each other, and in doing so, defying the isolation and fear that accompany serious health conditions. Bill Evans from Watson Health showed us how Watson is changing the face of medical research with its ability to “read” thousands of medical journals and white papers in unimaginable speeds in an effort to increase the safety and efficacy of clinical trials drugs.

Our Healthcare Startup Sharktank brought innovative thinking to the forefront of consumer health. Movi Interactive is incentivizing fitness tracker users in unique ways by gamifying their experiences to drive usage. Through their platform, Medprowellness is connecting consumers with clinicians, nutritionists, and personal trainers to provide a personalized layer of accountability to their 360-degree approach to health and wellness.

The marketer in me was excited about all the new ways data will continue to fuel our insights. Finding new ways to visualize data is critical, according to David Davenport Firth, particularly since 75% of physicians admit to not understanding the statistics in journals. Back to the topic of wearables… For a while now, marketers have been talking about the endless data streams being collected from wearables. Patrick Henshaw and his startup, Strap, can aggregate data from wearables, smartphones, and other apps, allowing marketers to draw insights from real-time human data. On a similar note, there was Pranav Yadav, whose company Neuro-Insight can help marketers and brands optimize their creative by analyzing the neuro-responses of their consumers.

We are at the crossroads of health, wellness, technology, and marketing. Ryan Olohan from Google reinforced the fact that like all successful companies, healthcare brands need to innovate or die. Companies like Kodak and Blockbuster didn’t, while companies like Uber and Expedia have changed their respective industries forever. As marketers in the healthcare space, we all need to look beyond our comfort zones. We need to encourage our brands to look beyond, as well.

This article was originally posted on Ivan Ruiz Graphic & Web Design.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, agency life, behavior change, Blogging, Branding, content marketing, Creativity, CRM, Culture, Customer Relationship Marketing, Data, Design, Digital, Digital Advertising, Global Marketing, Great Ideas, Health & Wellness, Healthcare Communications, Innovate, Multi Channel Marketing, Patient Communications, Payer Marketing, Social Media, Statistics, Strategy, Technology | Comments closed
Sep18

Infographic: Smartphone Use Among Physicians

In my first of a series of infographics on Digital Health, I look at smartphone use as a metric of digital acceptance and adoption among physicians. Like us, physicians are unquestionably connected through their smartphones, and are conditioned to receive digital content. The newest generation of physicians entering the field are digital natives, and do not know a world without the Internet or constant connectivity. These physicians will play a huge role in shaping the future of digital health. The key will be to understand how and when to best reach them, and those are topics we’ll cover in future posts.

Smartphones and the future of Healthcare

This article was originally posted on Ivan Ruiz Graphic & Web Design.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, behavior change, Creativity, Data, Design, Digital, Digital Advertising, Healthcare Communications, Infographics, Learning, Medical Education, Patient Communications, Presentations, SEO, Strategy | Comments closed
Sep3

Mobile in Healthcare: The Future?

Mobile Healthcare Blog ImageIn the past few years, mobile technology has changed the way consumers interact with their service providers. Whether ordering a cab to one’s exact location within minutes or getting groceries delivered in a matter of hours, there seems to be an app for everything. The healthcare industry is no exception to this trend. Mobile health data helps patients, doctors, and pharmaceutical companies in new and innovative ways.

Mobile technology is changing the way doctors and patients interact with both the healthcare system and with one another. The fitness wearables trend has put the power of transforming one’s health and body into the hands of the consumer. People use wearables and other mobile devices to get constant data feedback on their heart rate, steps, calories burned, etc. Many of these apps then organize and share this information in an easy-to-understand way, allowing consumers to make better decisions about their health. Patients can also use new apps, such as ZocDoc, which provide up-to-date appointment availability, enabling users to schedule visits with doctors as quickly and conveniently as possible. In fact, even more specific apps exist, such as Castlight, which compares prices of MRIs and other tests to find the most affordable options in a given location.1

Healthcare professionals also use a number of different apps to improve patient care and treatment. Indeed, there are entire sections of Apple’s App Store devoted to apps for doctors.2 Perhaps one of the most useful features in many of these apps is the ability to look up information right at the patient’s bedside. Quickly searching for certain symptoms can save crucial time for both the doctor and patient and may facilitate a more accurate diagnosis. Moreover, certain apps will soon offer on-the-go monitoring functionality, providing live feeds of patients’ vitals right to their doctors’ mobile devices. This continuous supply of information can optimize patient care and improve the healthcare system on a wider scale.

These mobile technologies are not just changing the way healthcare works in developed countries. Mobile has been incredibly helpful in transforming and improving the healthcare systems of many third world countries. This technology helps serve underprivileged societies by “addressing challenges such as reducing material and infant mortality rates, combatting infectious disease, creating awareness of HIV and delivering nutritional health and treatment for a variety of health conditions remotely.”3 CliniPAK360 is one app that has transformed treatment in Africa. The app works by allowing healthcare workers to input symptoms and information about a patient, which is then used to analyze and diagnose serious conditions. Other hospitals in Africa are using phones or tablets with preloaded medical information, which can be critical for saving time and effort in diagnosing and treating patients.

Mobile is also changing the way that healthcare marketers target consumers. Instead of simply “pushing pills,” companies now make their brands interactive and interesting to consumers, helping to change their brand image. Mobile apps help patients track their own health and progress and supply pharma companies with more data to effectively target consumers. Merck created MerckEngage, which provides health tracking services and has over 100,000 users from whom Merck can collect new insights and information. Geisinger Health System also launched an app on a small scale that studied “metrics like patient acceptance and treatment adherence to decide which solutions to these issues could be deployed on a broader scale” based on data they received from the app. Additionally, mobile apps can also help with medicine adherence by understanding which patients do not follow their prescription instructions and targeting them with more precise reminders. Pharma companies can leverage this data revolution to obtain the most accurate and useful marketing information yet.4

I have seen this mobile technology in my short time here at Ogilvy CommonHealth. In the past few weeks, I have helped work on an app which tracks a user’s sleep habits through either manual input or syncing up with a wearable device like Jawbone or Fitbit. This app is mutually beneficial as it helps the owners collect data on sleep habits nationwide, and helps users achieve greater awareness of their sleeping behaviors.

The central theme among all of these healthcare apps is optimization, data collection, and a better understanding of disease perception. Large databases of patient and consumer information now exist, which can be analyzed to streamline and improve patient experience, outcome, and overall health.5 It remains unclear how far these apps can take us, or if a piece of technology will ever be as good as a doctor’s intuition, but the continuing innovations provide a glimpse into the future of healthcare.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.
Read More »

Also posted in advertising, Analytics, behavior change, Data, Design, Digital, Health & Wellness, Healthcare Communications, Medical Education, Patient Communications, Strategy, Wearable Health Technology | Comments closed
Aug21

Helping Clients Navigate Compliant Communications for FDA-regulated Products

Helping Clients Navigate Compliant Communications for FDA-regulated Products IMAGE_EDVANITY URLS: Google Paid Search Engine Marketing (SEM) Changes
• Redirecting ad changes effective January 12, 2016
• Prohibiting ads where vanity URLs are utilized and dramatically different from the destination URL

Google has announced significant changes in their paid search engine advertising policies with regard to pharmaceutical products. The change that we are addressing here deals with vanity URLs, and their respective redirecting ads, that will take place in January 2016. The bottom line is that Google will no longer allow vanity URLs in an effort to provide consumers with more “clarity and transparency.”

Google has a long-standing policy prohibiting any ads where the destination URL differs dramatically from the display URL. Please note, this prohibition is not exclusively for pharmaceutical products—it has been Google’s practice across the board. Up until now, the pharmaceutical industry had been the exception to the rule. The reason for the exception was because in many cases, information seekers will not know the name of a drug, but will understand and know the symptoms/disease state information.

FDA background information
Previously, the FDA never objected to marketers utilizing vanity URLs and/or redirecting ads. These URLs/ads typically do not directly promote the name of a prescription product. Instead they lend themselves more to a disease state or descriptive nature, and then redirect users to another location or URL where they will see branded information specific to the prescription drug and/or disease state. Vanity URLs/redirecting ads are not exclusive to online SEM use, and are also used in print ads, television commercials, billboards, postcards, and more.
In March 2009, the FDA sent out 14 violation letters regarding search engine marketing practices of 48 brands. Thirteen of those violations referred to SEM ads running on Google. The FDA noted four types of violations in 2009:

  1. Omission of risk information, failure to meet requirements of 21 CRF 202.1(e)(5)(ii)
  2. Inadequate communication of indication
  3. Overstatement of efficacy
  4. Failure to use the required established name

Google’s reaction—what exactly is Google implementing?
Beginning in January 2016, Google will not permit pharmaceutical advertisers to have vanity URLs (such as “TreatmentforConditionX.com”) that redirect users to a BrandName.com website.

Pharmaceutical marketers will have the following options for vanity URLs:
Option 1

ConditionSymptomsGoogle-01

Sample ad showing company name as URL

Option 2
They can add “.com” to the company name.

ConditionSymptomsGoogle-02

Sample ad showing company name plus .com as URL

Option 3a (for prescription drugs, biologics, and vaccines)
They can display the phrase “Prescription treatment website” as the display URL.

ConditionSymptomsGoogle-03

Sample ad showing prescription treatment display URL

Option 3b (for medical devices)
They can display the phrase “Prescription device website” as the display URL.

ConditionSymptomsGoogle-04

Sample ad showing device display URL

All of these ads will be able to drive to pages on the brand.com or brandhcp.com website.

At the present time, this change has been instituted by Google only, and doesn’t lend itself to print, television, or other advertising mediums.

What does this mean for our clients?
Review and reassessment of live and proposed Google SEM campaigns where clients utilize vanity URLs need to be completed as soon as possible. New campaigns need to take these new rules into consideration during the tactical planning phase. Funds can be shifted to Yahoo and Bing, however there is the possibility that they may also follow suit.

Google has indicated a willingness to work with pharmaceutical clients to minimize potential negative impact to paid search campaign performance. Testing of the new formats will determine which type of units work best with various campaigns.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, Analytics, Apps, Brand Awareness, Branding, Clients, Content Strategy, Design, Digital, Digital Advertising, Health & Wellness, Healthcare Communications, Patient Communications, SEO, Statistics, Strategy, Technology, Uncategorized | Tagged | Comments closed
Aug5

Immunotherapy: Has the Answer to Cancer Been Inside Us All Along?

Immunology Blog Image EDThis year over 1.6 million Americans will be diagnosed with cancer and nearly 600,000 people will die from the disease. That’s over 1600 people each day. The need for innovative therapeutic approaches to treat cancer has never been higher. To help fight the tumor, oncologists are literally looking within at new immunotherapeutic approaches aimed at unleashing the body’s own natural defenses.

The idea of immunotherapy isn’t a new one. Since the first studies of antibodies began in 1891, researchers have continued to investigate the potential of the immune system. But the idea held little more than promise.

But all that has changed.

Numerous breakthrough advancements in immunotherapy, with unprecedented results, have propelled the entire class forward. At this year’s Annual Meeting of the American Society of Oncology (ASCO), immunotherapy took front and center. Thousands upon thousands of oncologists crammed the educational sessions for just a glimpse of some of the new data being presented, CNN ran headline news stories from the congress, and even patients are aware and asking their physicians about the new therapies being researched.

Across the board, the pharmaceutical industry has started to mobilize behind the potential of immunotherapy unlike anything else seen before. Most of the major pharmaceutical companies already have one or more new drug candidates in development—and if they don’t, they are aggressively exploring opportunities to catch up.

Over 800 Clinical Trials With Immunotherapy Products
At present there are 844 ongoing or completed clinical trials with immunotherapy drugs across a wide range of tumor types. These trials include some of the most challenging cancers associated with the worst prognoses, like lung, stomach, brain, and melanoma. And new trials with new products and new regimens are added almost daily.

$35 Billion in Projected Sales
Analysts believe that annual sales for immunotherapy products in oncology will reach $35 billion a year.

60% of Cancers Will be Treated With Immunotherapy

Researchers believe that immunotherapy may become the dominant form of treatment in oncology, with nearly two out of every three cancer patients receiving some form of immuno-based therapy within the next decade.

While these numbers are staggering, the greatest benefit may be for the patients diagnosed with cancer. The early results from the emerging next-generation immunotherapy agents have rightfully captured the hopes of both patients and oncologists. With continued research and a little luck, these treatments may provide more than a treatment for a cancer, they may offer a cure.

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in clinical trials, Health & Wellness, Healthcare Communications, Medical Education, Medicine, Pharmaceutical, Strategy | Tagged , | Comments closed
Jul15

Illuminate the Customer Journey With Data and Analytics

Journey Blog Image_EDSmart integration of data can now help identify and predict customer location and movement along the customer journey continuum. Mapping the customer journey is a vital planning tool.

Mapping out customer journeys is a well-established phase of communications planning. At Ogilvy, this represents the third step in the well-regarded planning platform: FUSION. The customer journey identifies the different phases customers migrate through toward a desired behavioral change destination. The journey phase will differ in each planning effort as the preferred consumer action and marketing objective are all project specific.

Improved understanding of the different stages customers should pass through en route to the ultimate desired location helps planners marshal the right channels, messages, and content to aid the customers along their journey.

The construct around the journey-based plan addresses key questions such as:

• What is our ideal behavioral perception for audiences in a specific stage?
• What are the perceptual challenges that may hinder getting our audience to think in a particular way?
• What are the positive levers that can enhance the likelihood of our audience to respond in a desired manner?
• How do we then move our consumers to the journey’s next phase?
• What channels do we deploy, and at what times, to get our key messages across our audience?

When these are well identified, the output helps make the ubiquitous, overused, but still aspirational goal of “right message, right channel, at the right time, to the right audience,” a possibility.

The customer journey can be complex: recent studies such as McKinsey’s The Consumer Decision Journey have shown that the customer journey has grown more complex. As I have alluded to in my previous article, The Marketing Funnel is Not Dead: A Website Analogy, customers may take several complex detours, but they still have to pass through well-defined phases to proceed with their conversion. The typical phases of this journey start with brand or message awareness and proceed to stimulating interest, trial, usage, commitment, and advocacy. Customers may get caught up in a phase, or proceed rapidly through phases, or even recede at times. However, you generally need to be aware of a product before you can consider using it.

The journey currently produces robust and well laid-out plans to engage and usher consumers on the behavioral change voyage. The next step is to map real customers to each phase and deliver plans against these customers to improve the journey. Before consumer-mapping knowledge, marketers have applied satisfactory approaches including contextual marketing, which aligns messages to media content as a proxy for consumer awareness and the journey phase. Sequential messaging is another approach without mapping knowledge. This approach starts with early-phase messaging and shifts to later-stage messaging based on average phrase duration. Lastly, one could always deliver broad messages, with the hope and expectation that the audience will self-select, and engage with the messages most applicable to their journey. However, the utilization of consumer-mapping information and understanding which individuals are in each phase are preferred.

The availability of customer-level data and the ease of pooling previously unconnected data are making customer mapping a reality. Now we can identify when a customer traverses a specific phase of the journey so that we can execute the well laid-out communication plan against these customers. Data can now help us to answer questions such as who are these customers. What is the likelihood that they will try the product? How quickly will they progress along the journey? How likely are they to become a highly valuable customer? Once the customer journey has been identified, planners and analysts can identify the attributes and traceable behavioral markers that correspond to each phase. Analysts then pool together vast available customer-level data, create new variables as needed, recommend new proxy measures, and categorize customers into their corresponding phase. This is the essence of marketing smart: integrating consumer mapping (segmentation) and targeting with planning from the start.

We recently categorized healthcare professionals (HCPs) into key journey phases using combined data including scripting volume (current value), category share (opportunity), and trajectory of prescription change over time (momentum), as well as other behavioral and attitudinal markers (attributes). We identified “the trialists” as customers who have a low volume of recent activities, or have remained static in their usage patterns. “Adopters” are users on an upward momentum who overindex on usage, while “the passionate advocates” have a large volume of usage and are still increasing their volume. The passionate advocates typically index well in terms of the category’s brand share. Since we can put a face to every target HCP within the customer journey’s important stages, allows us to map the communication plan, as well as behavioral change targets, to specific customers.

A journey infused with data makes evaluating and optimizing marketing effectiveness easier. Goals and targets should be set with behavioral outcome objectives for each customer segment, which makes tracking, assessment, and adjustment more feasible. When customers traverse into the journey’s next phase, the speed and momentum can be quantified, and the effect of channels and messages can be realized. A/B testing experiments are also beneficial to identify and amplify drivers (eg, tactics, content, execution) that have proven effective in engaging and moving customers into the next phase.

In conclusion, data, and the attendant analysis, can enhance our understanding of audiences along the customer journey, thereby enhancing more relevant communication, engagement, and desired responses from our customers. Marketers who put the customer-mapping capability to better use will reap the results of increased customer velocity along the journey, better customer experience with the brand, and higher value per customer.

1 http://www.mckinsey.com/insights/marketing_sales/the_consumer_decision_journey
2 https://digitaliy.wordpress.com/2011/10/15/the-marketing-funnel-is-not-dead-a-website-analogy/

CONTINUE THE CONVERSATION:
Questions? Comments? You can contact the author directly at blog@ochww.com.
Please allow 24 hours for response.

Also posted in advertising, Analytics, behavior change, Data, Design, Digital, Healthcare Communications, Marketing, Strategy, Technology | Comments closed